首页/数据集/Mass spectrometry results of tumor cells treated with PROTAC targeting BCL3

Mass spectrometry results of tumor cells treated with PROTAC targeting BCL3

Name: Mass spectrometry results of tumor cells treated with PROTAC targeting BCL3
Creator: The Seventh Affiliated Hospital of Sun Yat sen University
Published: 2024-08-08T12:32:33+08:00

integrated proteome resources2026-02-07 收录

靶向蛋白降解

肿瘤蛋白质组学

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0009445000 数据链接链接失效反馈

官方服务：

资源简介：

Mass spectrometry results of tumor cells treated with PROTAC targeting BCL3

应用场景：

提供机构：

The Seventh Affiliated Hospital of Sun Yat sen University

创建时间：

2024-08-08

肿瘤蛋白质组学

癌症生物标志物

Comparative proteome analysis of BL and DLBCL cell lines, cryopreserved and formalin-fixed paraffin-embedded (FFPE) primary tumor specimens by SWATH-MS.

NIAID Data Ecosystem50

Proteomic profiling of glioblastoma stem cells and their small extracellular vesicles

肿瘤蛋白质组学

细胞外囊泡功能研究

The heterogeneous nature of glioblastoma stem-like cells (GSCs) creates hurdles in developing effective therapies against glioblastoma, making it extremely difficult to eradicate. In this part of the

NIAID Data Ecosystem30

Proteomics Identified Overexpression of SET Oncogene Product and Possible Therapeutic Utility of Protein Phosphatase 2A in Alveolar Soft Part Sarcoma

肿瘤蛋白质组学

肉瘤靶向治疗

Alveolar soft part sarcoma (ASPS) is an exceedingly rare sarcoma refractory to standard chemotherapy. Although several molecular targeting drugs have been applied for ASPS, their clinical significance

Figshare2016-02-17 更新20

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma

黑色素瘤生物标志物

肿瘤蛋白质组学

Background Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neither a prognostic marker nor a specific and lasting treatment. Proteomic analysis is a ver

NIAID Data Ecosystem40

Discovery of LL-K8-22: A Selective, Durable, and Small-Molecule Degrader of the CDK8-Cyclin C Complex

靶向蛋白降解

CDK8-cyclinC抗肿瘤靶点

The CDK8–cyclin C complex is an important anti-tumor target, but unlike CDK8, cyclin C remains undruggable. Modulators regulating cyclin C activity directly are still under development. Here, a series

Figshare2023-03-17 更新30

Mass spectrometry results of tumor cells treated with PROTAC targeting BCL3

资源简介：

相关数据集